What are the diagnostic and treatment steps for HELLP syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis and Treatment of HELLP Syndrome

The definitive management of HELLP syndrome requires immediate delivery after maternal stabilization, regardless of gestational age, as it represents a serious complication with significant maternal mortality risk of 2-24%. 1

Diagnostic Criteria for HELLP Syndrome

HELLP syndrome is diagnosed clinically based on the following laboratory findings:

  • H (Hemolysis)

    • Evidence of microangiopathic hemolytic anemia on peripheral blood smear
    • Elevated lactate dehydrogenase (LDH) > 600 U/L
    • Decreased haptoglobin levels
  • EL (Elevated Liver Enzymes)

    • Aspartate aminotransferase (AST) ≥ 70 U/L
    • Alanine aminotransferase (ALT) elevated (typically > 45 U/L)
  • LP (Low Platelets)

    • Platelet count < 100,000/mm³

Clinical Presentation

  • Right upper quadrant or epigastric pain (65% of cases)
  • Nausea and vomiting (35%)
  • Headache (30%)
  • Malaise
  • Jaundice (up to 40%)
  • Hypertension (85% of cases)
  • Proteinuria (common but not required)
  • Weight gain and peripheral edema 1, 2

Diagnostic Steps

  1. Laboratory testing:

    • Complete blood count with peripheral smear
    • Liver function tests (AST, ALT, LDH, bilirubin)
    • Coagulation studies (PT, aPTT, fibrinogen, fibrin degradation products)
    • Renal function tests
    • Urinalysis for proteinuria 3, 2
  2. Abdominal imaging:

    • Perform abdominal imaging to rule out hepatic hemorrhage, infarct, or rupture 1
  3. Differential diagnosis:

    • Acute fatty liver of pregnancy
    • Viral hepatitis
    • Cholecystitis
    • Thrombotic thrombocytopenic purpura
    • Hemolytic uremic syndrome
    • Immune thrombocytopenic purpura 4

Treatment Algorithm

1. Maternal Stabilization

  • Control severe hypertension (SBP ≥160 mmHg and/or DBP ≥110 mmHg):

    • First-line medications: IV labetalol, IV hydralazine, or oral nifedipine
    • Target blood pressure: diastolic 85 mmHg, systolic 110-140 mmHg 3
  • Seizure prophylaxis:

    • Administer magnesium sulfate
    • Continue for at least 24 hours postpartum 3
  • Correct coagulopathy:

    • Transfuse platelets if count < 50,000/mm³, especially prior to cesarean section
    • Administer fresh frozen plasma to correct coagulopathy if needed
    • Transfuse whole blood or packed red cells if hemoglobin < 10 g/dL 3, 1

2. Delivery Planning

  • Immediate delivery is the definitive treatment regardless of gestational age after maternal stabilization 1, 3

  • Mode of delivery:

    • Vaginal delivery is preferable if the maternal condition is stable and cervix is favorable
    • If cervix is unfavorable, consider cervical ripening followed by induction
    • Cesarean section if maternal condition is deteriorating or there are signs of fetal distress 5
  • Corticosteroids:

    • For gestational ages between 24-34 weeks, administer corticosteroids for fetal lung maturation
    • Single course: either 2 doses of 12 mg betamethasone 24 hours apart or 6 mg dexamethasone 12 hours apart 5, 3

3. Postpartum Management

  • Intensive monitoring:

    • Continue close surveillance for at least 48 hours after delivery
    • Monitor in high dependency unit with central venous pressure, urinary output, blood pressure, ECG, and oxygen saturation 1, 5
  • Laboratory monitoring:

    • Monitor platelet count and LDH as the best indicators of disease progression
    • Continue monitoring liver enzymes, renal function, and coagulation parameters
    • Laboratory abnormalities typically peak 24 hours after delivery and resolve over several days 5, 6
  • Blood pressure control:

    • Continue antihypertensive medications as needed
    • Monitor blood pressure every 4-6 hours for at least 3 days
    • Taper antihypertensive medications slowly after days 3-6 3

Important Considerations

  • HELLP syndrome occurs in 0.2-0.6% of all pregnancies and in 10-20% of cases with severe preeclampsia 5
  • About 70% of cases develop before delivery, with the majority occurring between 27-37 weeks gestation 5
  • HELLP syndrome can occur without typical signs of preeclampsia (hypertension and proteinuria) in up to 20% of cases 4
  • Maternal mortality ranges from 2-24%, highlighting the importance of prompt diagnosis and treatment 1
  • HELLP syndrome complicated by hepatic rupture or acute liver failure should prompt transfer to a transplant center for evaluation 1

Pitfalls to Avoid

  • Delayed diagnosis: Consider HELLP syndrome in all pregnant women with upper abdominal pain, regardless of presence of preeclampsia symptoms 4
  • Misdiagnosis: HELLP can mimic other conditions such as acute cholecystitis, viral hepatitis, or thrombotic microangiopathies 4, 7
  • Inadequate monitoring: The syndrome may worsen rapidly, requiring close monitoring of laboratory parameters and maternal condition 7
  • Prolonged conservative management: Delaying delivery can lead to increased maternal and fetal complications 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Differential HELLP syndrome diagnosis].

Zeitschrift fur Geburtshilfe und Neonatologie, 1996

Research

The HELLP syndrome: clinical issues and management. A Review.

BMC pregnancy and childbirth, 2009

Research

A review of HELLP syndrome.

Journal of perinatology : official journal of the California Perinatal Association, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.